Virtual talk via Zoom: https://mit.zoom.us/j/443735780
One tap mobile
+16465588656,,443735780# US (New York)
+16699006833,,443735780# US (San Jose)
Dial US : +1 646 558 8656 or +1 669 900 6833
Meeting ID: 443 735 780
International Numbers: https://mit.zoom.us/u/aiS2rJKBO
abstract: Dr. Lin will describe the basic biology of coronaviruses and the disease COVID-19, projections for the current epidemic, and review medications currently in clinical trials.
Michael Lin is Associate Professor of Neurobiology, Bioengineering, and Chemical and Systems Biology at Stanford University. The Lin lab applies biochemical and engineering principles to the development of protein-based tools for investigating biology in living animals. Topics of investigation include fluorescent protein-based voltage indicators, synthetic light-controllable proteins, bioluminescent reporters, and applications to studying animal models of disease.
Michael Lin received an A.B. summa cum laude in Biochemistry from Harvard in 1994, a PhD in Biological and Biomedical Sciences from Harvard Medical School in 2002, and a MD degree from UCLA in 2004. Dr. Lin then received postdoctoral training with Chemistry Nobel Laureate Roger Y. Tsien at UCSD. Dr. Lin was appointed Assistant Professor of Pediatrics and Bioengineering at Stanford in 2009, and Associate Professor of Neurobiology and Bioengineering in 2015. At Stanford, Dr. Lin leads a research group developing protein-based tools for imaging and controlling biological processes. Among these are methods adapting antiviral drugs and viral proteases to control protein stability and contruct synthetic signaling circuits. Dr. Lin is a recipient of a Burroughs Wellcome Career Award for Medical Scientists, a Rita Allen Scholar Award, a Damon Runyon-Rachleff Innovation Award, the NIH Pioneer Award, and the World Molecular Imaging Society Roger Y. Tsien Award.